Your browser doesn't support javascript.
loading
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial.
López, Pio; López-Medina, Eduardo; Sáez-Llorens, Xavier; deAntonio, Rodrigo; Masuda, Taisei; Mendelman, Paul M; Sherwood, James; Baehner, Frank; Borkowski, Astrid.
Afiliação
  • López P; Department of Pediatrics, Centro de Estudios en Infectología Pediátrica S.A.S., Cali, Colombia.
  • López-Medina E; Department of Pediatrics, Centro de Estudios en Infectología Pediátrica S.A.S., Cali, Colombia.
  • Sáez-Llorens X; Department of Infectology, Cevaxin, The Panama Clinic, Panama City, Panama.
  • deAntonio R; Infectious Diseases, Hospital del Niño Dr. José Renán Esquivel, Panama City, Panama.
  • Masuda T; Medicine (Pediatrics and Infectious Diseases), SNI, National Secretariat of Science, Technology and Innovation (SENACYT), Panama City, Panama.
  • Mendelman PM; Department of Infectology, Cevaxin, The Panama Clinic, Panama City, Panama.
  • Sherwood J; Clinical Development, Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Baehner F; Clinical Development, Takeda Vaccines Inc., Cambridge, MA, USA.
  • Borkowski A; Clinical Development, Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Hum Vaccin Immunother ; 19(1): 2204787, 2023 12 31.
Article em En | MEDLINE | ID: mdl-37140558

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Norovirus / Vacinas de Partículas Semelhantes a Vírus Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Norovirus / Vacinas de Partículas Semelhantes a Vírus Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2023 Tipo de documento: Article